NASDAQ:XAIR - Beyond Air Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $12.20
  • Forecasted Upside: 56.61 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$7.79
▼ -0.09 (-1.14%)

This chart shows the closing price for XAIR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Beyond Air Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XAIR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XAIR

Analyst Price Target is $12.20
▲ +56.61% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Beyond Air in the last 3 months. The average price target is $12.20, with a high forecast of $17.00 and a low forecast of $9.00. The average price target represents a 56.61% upside from the last price of $7.79.

This chart shows the closing price for XAIR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Beyond Air.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/9/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/9/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/7/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/3/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/22/2021Roth CapitalReiterated RatingBuyC$11.00Low
6/22/2021LADENBURG THALM/SH SHReiterated RatingBuyC$17.00Low
6/18/2021OppenheimerReiterated RatingBuy$9.00High
6/15/2021Roth CapitalReiterated RatingBuyMedium
4/28/2021Truist SecuritiesInitiated CoverageBuy$12.00High
4/28/2021TruistInitiated CoverageBuy$12.00High
9/22/2020OppenheimerReiterated RatingBuy$9.00High
6/23/2020OppenheimerReiterated RatingBuy$9.00Medium
10/22/2019OppenheimerInitiated CoverageOutperform$9.00 ➝ $9.00High
(Data available from 8/2/2016 forward)
Beyond Air logo
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Read More

Today's Range

Now: $7.79
Low: $7.59
High: $8.03

50 Day Range

MA: $6.18
Low: $4.72
High: $8.40

52 Week Range

Now: $7.79
Low: $4.62
High: $9.30

Volume

282,173 shs

Average Volume

438,044 shs

Market Capitalization

$181.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Beyond Air?

The following sell-side analysts have issued stock ratings on Beyond Air in the last year: LADENBURG THALM/SH SH, Oppenheimer Holdings Inc., Roth Capital, Truist, Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for XAIR.

What is the current price target for Beyond Air?

5 Wall Street analysts have set twelve-month price targets for Beyond Air in the last year. Their average twelve-month price target is $12.20, suggesting a possible upside of 56.6%. LADENBURG THALM/SH SH has the highest price target set, predicting XAIR will reach $17.00 in the next twelve months. Oppenheimer Holdings Inc. has the lowest price target set, forecasting a price of $9.00 for Beyond Air in the next year.
View the latest price targets for XAIR.

What is the current consensus analyst rating for Beyond Air?

Beyond Air currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe XAIR will outperform the market and that investors should add to their positions of Beyond Air.
View the latest ratings for XAIR.

What other companies compete with Beyond Air?

How do I contact Beyond Air's investor relations team?

Beyond Air's physical mailing address is 825 EAST GATE BOULEVARD SUITE 320, GARDEN CITY NY, 11530. The company's listed phone number is 516-665-8200. The official website for Beyond Air is www.ait-pharm.com.